VolitionRX Limited Common Stock (VNRX)
0.5841
0.00 (0.00%)
VolitionRx Ltd is a biotechnology company focused on developing diagnostic tests for detecting a variety of cancers and other diseases through innovative blood-based technologies
The company's primary approach involves utilizing its proprietary Nu.Q platform, which analyzes Nucleosomes—fragments of DNA that can indicate the presence of cancer. By providing accessible and accurate diagnostic tools, VolitionRx aims to enhance early detection and improve patient outcomes in oncology and beyond, ultimately contributing to more effective and personalized healthcare solutions.